Day 321

Johnson & Johnson today announced that the company has filed its Emergency approval application with the FDA to get their COVID-19 vaccine approved. The efficacy of the single dose vaccine that is expected to be approved within two weeks, is listed to be 66% which could help get more people vaccinated.